Humasis Co. Ltd.

KOSDAQ 205470.KQ

Humasis Co. Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -4.55 M

Humasis Co. Ltd. Net Cash Used Provided By Financing Activities is USD -4.55 M for the year ending December 31, 2023, a 84.58% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Humasis Co. Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -29.54 M, a -192.81% change year over year.
  • Humasis Co. Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -10.09 M, a -510.38% change year over year.
  • Humasis Co. Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 2.46 M, a 6.50% change year over year.
  • Humasis Co. Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 2.31 M, a -63.10% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
KOSDAQ: 205470.KQ

Humasis Co. Ltd.

Description

Humasis Co. Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. It offers pregnancy and ovulation self-test products; Hubi-Quan Pro, a self-contained and cartridge reader to provide rapid quantitative results for membrane-based lateral flow immunochromatographic assays; and various rapid test kits. The company was founded in 2000 and is based in Anyang, South Korea.

Similar companies

200130.KQ

Kolmar BNH Co., Ltd.

USD 8.18

-3.91%

041190.KQ

Woori Technology Investment Co., Ltd

USD 4.63

-8.24%

096530.KQ

Seegene, Inc.

USD 15.77

-2.26%

StockViz Staff

February 4, 2025

Any question? Send us an email